openPR Logo
Press release

Former Factory Worker Launches Financial Education Project for Workers: "Economic Freedom Is Not Just for Graduates"

09-06-2025 12:56 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Former Factory Worker Launches Financial Education Project

September 5, 2025 - Emmanuel Onofaro, founder of the financial education project Obiettivo Riscatto Milionario , has announced the expansion of his free mentorship program dedicated to factory workers, retirees, and low-income earners, after reaching more than 1,800 participants in the first 18 months.

The initiative, born from Onofaro's personal experience as a factory worker, aims to democratize access to financial education through a practical and accessible approach, removing the technical jargon that often distances working-class people from investing.

From the lathe to mentoring: a story of resilience

Onofaro left the factory after what he calls "the turning point": seeing older colleagues resigned to a life of routine without prospects. "That wasn't the future I wanted for myself," he recalls from the office he set up above the bar where he had once worked as a waiter.

His transition was not immediate. After several failed attempts and bad investments that cost him his first savings, Onofaro developed a systematic method for managing capital, which he now shares for free through evening webinars and a large community.

A different approach to financial education

"Most finance courses are designed for those who already have significant capital," explains Onofaro. "I speak the language of those who wake up at 5 a.m. to clock in at work."

The program includes:

* Free evening webinars three times a week
* One-on-one mentorship for more complex cases
* A support group with over 1,800 active members
* Simplified educational materials without technical jargon

Tangible results and social impact

According to platform data, 73% of participants reported improving their financial situation within the first 90 days, with particularly strong results among retirees earning less than 1,000 per month.

Mario Carbone, a 67-year-old retiree from Padua, testifies: "For the first time I understood how to make my small savings grow without relying on the bank. Emmanuel's simple language made all the difference."

The "Give First" model

Onofaro sustains his project through what he calls the "Give First model": offering free education while supporting himself through private consulting. "I don't want to become just another guru selling 2,000 courses," he says firmly. "My mission is to prove that financial freedom is not reserved for those born privileged. If I did it, starting from zero and without a degree, anyone can."

Next steps By 2026, Onofaro plans to:

* Expand the program nationwide
* Launch a mobile app to make the content even more accessible
* Publish a simplified book on financial education

The role of martial arts in financial discipline

A practitioner of MMA and kickboxing, Onofaro credits much of his success to the discipline learned in the ring. "Martial arts taught me that every defeat is a lesson. The same is true for investing: what matters is getting back up and learning."

His most meaningful tattoo represents his motto: "Lupus non timet cane latratem" ("The wolf does not fear the barking dog"), symbolizing his determination to pursue his goals despite criticism.

About Obiettivo Riscatto Milionario

Founded in 2023, this financial education project was created to make investing accessible to working-class people. With over 1,800 active members and a 92% satisfaction rate, it stands as one of the most innovative financial inclusion programs in Italy.

Disclaimer: This press release may contain forward-looking statements. Forward-looking statements describe future expectations, plans, results, or strategies (including product offerings, regulatory plans and business plans) and may change without notice. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements.

Media Contact
Company Name: Trading Solutions Investing Quotation LLC
Contact Person: Emmanuel Onofaro
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=former-factory-worker-launches-financial-education-project-for-workers-economic-freedom-is-not-just-for-graduates]
Country: United States
Website: https://obiettivo30giorni.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Former Factory Worker Launches Financial Education Project for Workers: "Economic Freedom Is Not Just for Graduates" here

News-ID: 4172364 • Views:

More Releases from ABNewswire

Alpha-1 Antitrypsin Deficiency Pipeline Drugs Insights Report 2025: Emerging Therapies and Innovation Trends by DelveInsight
Alpha-1 Antitrypsin Deficiency Pipeline Drugs Insights Report 2025: Emerging The …
DelveInsight's "Alpha-1 Antitrypsin Deficiency Vasculitis Pipeline Insight 2025" report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in the Alpha-1 Antitrypsin Deficiency Vasculitis pipeline landscape. It covers the Alpha-1 Antitrypsin Deficiency Vasculitis Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Alpha-1 Antitrypsin Deficiency Vasculitis Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline
Myelodysplastic Syndrome Pipeline Drugs Insights Report 2025: Emerging Therapies and Innovation Trends by DelveInsight
Myelodysplastic Syndrome Pipeline Drugs Insights Report 2025: Emerging Therapies …
DelveInsight's, "Myelodysplastic Syndrome Pipeline Insights 2025" report provides comprehensive insights about 120+ companies and 150+ pipeline drugs in Myelodysplastic Syndrome pipeline landscape. It covers the Myelodysplastic Syndrome pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Myelodysplastic Syndrome pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Download our comprehensive report now to
ESR1 mutated metastatic breast cancer Market Analysis 2034 - Competitive Landscape, Clinical Trials, Market Share, Therapies, Prevalence, and Key Players by DelveInsight
ESR1 mutated metastatic breast cancer Market Analysis 2034 - Competitive Landsca …
The ESR1-mutated metastatic breast cancer companies are AstraZeneca, Olema Pharmaceuticals, Arvinas, Sermonix Pharmaceuticals, Roche, Eli Lilly and Company, H3 Biomedicine, Eisai, Pfizer, Sun Pharma Advanced Research Company, Zenopharm, Daiichi Sankyo, and others. ESR1-mutated metastatic breast cancer market, valued at approximately USD 1.3 billion in 2023, is projected to experience substantial growth during the forecast period (2024-2034). Furthermore, the US accounts for the largest market share, representing approximately 63% of the total
Psychosis in Parkinson's and Alzheimer's Disease Market Analysis 2034 - Competitive Landscape, Clinical Trials, Market Share, Therapies, Prevalence, and Key Players by DelveInsight
Psychosis in Parkinson's and Alzheimer's Disease Market Analysis 2034 - Competit …
Key Psychosis in Parkinson's and Alzheimer's Disease companies actively developing therapies in this space include Karuna Therapeutics, Sunovion Pharmaceuticals, Intra-Cellular Therapies, Acadia Pharmaceuticals, and others. Promising pipeline candidates include NUPLAZID, Ulotaront, KarXT, ITI-1284, among others. DelveInsight has launched a new report on "Psychosis in Parkinson's and Alzheimer's Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Psychosis in Parkinson's and Alzheimer's Disease, historical and forecasted

All 5 Releases


More Releases for Onofaro

"The Fighter's Mindset in Investing": How a Former Factory Worker Applies MMA Di …
Milan - September 5, 2025 - Emmanuel Onofaro, mixed martial arts practitioner and founder of Obiettivo Riscatto Milionario , is applying principles of combat emotional control to financial management, with striking results. His approach, which combines pre-fight breathing techniques with investment decision-making, offers an innovative perspective on handling emotions in financial markets. From the ring to the portfolio: same control, different arenas "When you step into the ring, adrenaline can be your